» Articles » PMID: 20375209

Clinical Review 2: Genetic Determinants of Bone Density and Fracture Risk--state of the Art and Future Directions

Overview
Specialty Endocrinology
Date 2010 Apr 9
PMID 20375209
Citations 22
Authors
Affiliations
Soon will be listed here.
Abstract

Context: Osteoporosis is a common, highly heritable condition that causes substantial morbidity and mortality, the etiopathogenesis of which is poorly understood. Genetic studies are making increasingly rapid progress in identifying the genes involved.

Evidence Acquisition And Synthesis: In this review, we will summarize the current understanding of the genetics of osteoporosis based on publications from PubMed from the year 1987 onward.

Conclusions: Most genes involved in osteoporosis identified to date encode components of known pathways involved in bone synthesis or resorption, but as the field progresses, new pathways are being identified. Only a small proportion of the total genetic variation involved in osteoporosis has been identified, and new approaches will be required to identify most of the remaining genes.

Citing Articles

Selective Pyk2 inhibition enhances bone restoration through SCARA5-mediated bone marrow remodeling in ovariectomized mice.

Liu Y, Nishiura M, Fujii M, Sandhu S, Yawaka Y, Yamazaki Y Cell Commun Signal. 2024; 22(1):561.

PMID: 39578816 PMC: 11583405. DOI: 10.1186/s12964-024-01945-8.


Identification of osteoporosis genes using family studies.

Schembri M, Formosa M Front Endocrinol (Lausanne). 2024; 15:1455689.

PMID: 39502568 PMC: 11534825. DOI: 10.3389/fendo.2024.1455689.


Variability in performance of genetic-enhanced DXA-BMD prediction models across diverse ethnic and geographic populations: A risk prediction study.

Liu Y, Meng X, Wu C, Su K, Liu A, Tian Q PLoS Med. 2024; 21(8):e1004451.

PMID: 39213443 PMC: 11404845. DOI: 10.1371/journal.pmed.1004451.


Low bone mineralization in phenylketonuria may be due to undiagnosed metabolic acidosis.

Rovelli V, Ercoli V, Dionigi A, Paci S, Salvatici E, Zuvadelli J Mol Genet Metab Rep. 2023; 36:100998.

PMID: 37600232 PMC: 10432846. DOI: 10.1016/j.ymgmr.2023.100998.


Examining Whether Genetic Variants Moderate the Skeletal Effects of Selective Serotonin Reuptake Inhibitors in Older Adolescents and Young Adults.

Ezenwabachili I, Deumic Shultz E, Mills J, Ellingrod V, Calarge C J Child Adolesc Psychopharmacol. 2023; 33(7):260-268.

PMID: 37579130 PMC: 10517324. DOI: 10.1089/cap.2023.0007.